CCEA approves Strides' $1.6 billion deal with Mylan

The government cleared the $1.6 billion deal of the US-based Mylan Inc for acquiring Bangalore-based pharma firm Agila Specialties, a subsidiary of Strides Arcolab.
Share this Video
appinstlBnr
Open in App
Success
This article has been saved